SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding SQZ Biotechnologies Co changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 53 | 2 | 53 | +2 |
| Shares | 15.9M | 54.0K | 14.8M | −1.05M (−6.6%) |
| Value | $76.6M | $260.0K | $47.1M | −$29.2M (−38.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held SQZ Biotechnologies Co at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 431,400 | $1.37M | 0.06% |
| Ergoteles LLC | 104,323 | $332.0K | 0.01% |
| Millennium Management LLC | 92,286 | $293.0K | 0.00% |
| RBF Capital, LLC | 80,000 | $254.0K | 0.02% |
| Renaissance Technologies LLC | 57,903 | $184.0K | 0.00% |
| Dakota Wealth Management | 20,000 | $64.0K | 0.01% |
| Qube Research & Technologies Ltd | 19,902 | $63.0K | 0.00% |
| Dimensional Fund Advisors LP | 16,018 | $51.0K | 0.00% |
| HSBC Holdings PLC | 11,495 | $37.0K | 0.00% |
| Prudential Financial Inc | 11,450 | $36.0K | 0.00% |
| Occudo Quantitative Strategies LP | 11,307 | $36.0K | 0.00% |
| Russell Investments Group, Ltd. | 8,192 | $26.0K | 0.00% |
| Ronald Blue Trust, Inc. | 4,195 | $20.0K | 0.00% |
| UBS Group AG | 2,993 | $10.0K | 0.00% |
| National Bank of Canada | 1,000 | $3.00K | 0.00% |
| Group One Trading, L.P. | 1,000 | $3.00K | 0.00% |
| Advisor Group Holdings, Inc. | 256 | $1.00K | 0.00% |
| Credit Suisse AG | 12 | $0 | 0.00% |
Sold out (16)
Institutions that held SQZ Biotechnologies Co at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Alphabet Inc. | 103,929 | $500.0K |
| Nuveen Asset Management, LLC | 77,754 | $370.0K |
| Bank of New York Mellon Corp | 71,440 | $343.0K |
| Jacobs Levy Equity Management, Inc | 67,609 | $325.0K |
| Charles Schwab Investment Management Inc | 60,693 | $292.0K |
| Rhumbline Advisers | 25,148 | $121.0K |
| Two Sigma Advisers, LP | 21,000 | $101.0K |
| Allspring Global Investments Holdings, LLC | 16,713 | $80.0K |
| Deutsche Bank AG | 12,357 | $59.0K |
| California State Teachers Retirement System | 9,758 | $47.0K |
| Amalgamated Bank | 2,753 | $13.0K |
| Tower Research Capital LLC (TRC) | 2,254 | $11.0K |
| Legal & General Group Plc | 1,817 | $9.00K |
| Ameritas Investment Partners, Inc. | 1,785 | $9.00K |
| Royal Bank of Canada | 1,398 | $7.00K |
| Toronto Dominion Bank | 3 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held SQZ Biotechnologies Co at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 51,291 | $247.0K |
| Amalgamated Financial Corp. | 2,753 | $13.0K |